SCHEMBL31370844

SCHEMBL31370844

Cc1ccc(N(C)C(C)C(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
TSHR P16473 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
RAB9A P51151 1/20 0.39
ALOX5 P09917 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8605929 1.00 ALDH1A1 (0.44) ALDH1A1TSHRSMN1; SMN2SLC6A2SLC6A4
SCHEMBL755703 0.83 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2SLC6A2SLC6A4
SCHEMBL755702 0.83 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2SLC6A2SLC6A4
SCHEMBL7801107 0.82 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2SLC6A2SLC6A4
SCHEMBL7806144 0.82 KMT2A (0.43) SLC6A2SLC6A4KEAP1NFE2L2HDAC3
SCHEMBL7402365 0.82 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2SLC6A2SLC6A4
SCHEMBL7806141 0.82 KMT2A (0.43) SLC6A2SLC6A4KEAP1NFE2L2HDAC3
SCHEMBL29888718 0.82 KMT2A (0.49) ALDH1A1TSHRSMN1; SMN2RAB9AHDAC3
Hydrochloric Acid SCHEMBL8226909 0.82 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL32662705 0.82 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2024-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES BCAT1, BCAT2, PELP1 ALDH1A1 4472/4885TSHR 2791/4885SMN1; SMN2 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.